March 14, 2022
Sanofi’s Phase 2 Clinical Trial for Breast Cancer Drug Fails to Meet Primary Endpoint
The Phase 2 AMEERA-3 clinical trial evaluating amcenestrant, an investigational optimized oral selective estrogen receptor degrader (SERD), did not meet…